UPECLIN - Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu
Welcome,         Profile    Billing    Logout  
 0 Trials 
10 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pompilio, Mauricio A
ATTACC-CAP, NCT05848713: AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia

Recruiting
3
4000
Canada, US, RoW
Heparin
University of Manitoba, Canadian Institutes of Health Research (CIHR), Research Manitoba, Ozmosis Research Inc., Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network, Canadian Critical Care Trials Group, AVANTI
Community-acquired Pneumonia
03/28
03/29
Antunes, Murillo
ACTIV-4, NCT04505774 / 2020-004285-19: Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE

Completed
4
3591
Europe, US, RoW
theraputic heparin, unfractionated heparin, Enoxaparin, Dalteparin, Tinzaparin, Heparin, prophylactic heparin, enoxaparin, dalteparin, Fondparinux, P2Y12, Ticagrelor, Prasugrel, Clopidogrel, Crizanlizumab Injection, SGLT2 inhibitor, dapagliflozin, empagliflozin, canagliflozin, ertugliflozin
Matthew Neal MD, National Heart, Lung, and Blood Institute (NHLBI)
Covid19
08/23
01/24
NCT04591210: The COVID-RASi Trial (COVID-19)

Active, not recruiting
3
1155
Canada, RoW
Angiotensin converting enzyme inhibitor, Angiotensin II Receptor Blockers
Ottawa Heart Institute Research Corporation
COVID-19, Cardiovascular Diseases
12/24
12/25
OPTION TREAT, NCT05920005: Candesartan Cilexetil + Chlorthalidone + Amlodipine Versus Exforge HCT®️ for Systemic Arterial Hypertension

Recruiting
3
698
RoW
candesartan cilexetil + chlorthalidone + amlodipine, Exforge HCT® (valsartan 160mg + hydrochlorothiazide 12.5mg + amlodipine 5mg)
Hospital Israelita Albert Einstein, Libbs Farmacêutica LTDA
Hypertension
12/23
07/24
NEOMINDSET, NCT04360720: PercutaNEOus Coronary Intervention Followed by Monotherapy INstead of Dual Antiplatelet Therapy in the SETting of Acute Coronary Syndromes: The NEO-MINDSET Trial

Recruiting
3
3400
RoW
Antiplatelet Monotherapy
Hospital Israelita Albert Einstein
Acute Coronary Syndrome
01/24
01/24
NCT06242483: The ELFIE-HYPERTENSION

Recruiting
N/A
866
RoW
Elfie Solution
Hospital Israelita Albert Einstein, Elfie Pte. Ltd.
Hypertension
07/25
07/25
SAPPHIRE-LDL, NCT05622929: Cluster Randomized Trial of a Digital Quality Improvement Intervention on LDLCholesterol Control

Active, not recruiting
N/A
1465
RoW
Digitally-enabled Multifaceted Quality Improvement Intervention, Usual care
Hospital Israelita Albert Einstein, epHealth primary care solutions, Novartis
Cardiovascular Diseases, Atherosclerosis, Dyslipidemias
12/24
06/25
RADICALPC, NCT03127631: A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients

Recruiting
N/A
6000
Canada, US, RoW
Nutrition, Exercise, Smoking cessation, Statin (such as Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin), ACE inhibitor
McMaster University, Prostate Cancer Canada, Canadian Cancer Society (CCS)
Prostate Cancer, Cardiovascular Disease
12/26
12/26
Tanni, Suzana Erico
ATTACC-CAP, NCT05848713: AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia

Recruiting
3
4000
Canada, US, RoW
Heparin
University of Manitoba, Canadian Institutes of Health Research (CIHR), Research Manitoba, Ozmosis Research Inc., Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network, Canadian Critical Care Trials Group, AVANTI
Community-acquired Pneumonia
03/28
03/29
NCT06673225: INSPIRE Respiratory Health Program in Botucatu, São Paulo, Brazil

Recruiting
N/A
2000
RoW
Analysis of results
UPECLIN HC FM Botucatu Unesp, Conselho Nacional de Desenvolvimento Científico e Tecnológico
Community Health Services, Respiratory Disease, Tobacco Smoking
04/29
12/29

Download Options